Clinical trials
Multiple Sclerosis trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2008 | 1 |
| 2010 | 2 |
| 2014 | 3 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 9 |
| 2025 | 7 |
| 2026 | 14 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 20 |
| Completed | 10 |
| Not yet recruiting | 8 |
| Unknown status | 6 |
| Withdrawn | 3 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sanofi | 7 |
| Tongji Hospital | 7 |
| Xuanwu Hospital, Beijing | 4 |
| Beijing Tiantan Hospital | 3 |
| Daishi Tian | 3 |
| Biogen | 2 |
| Guangzhou Lupeng Pharmaceutical Company LTD. | 2 |
| Third Affiliated Hospital, Sun Yat-Sen University | 2 |
| Tianjin Huanhu Hospital | 2 |
| Bayer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 52 |
| Neuromyelitis Optica | 19 |
| Myasthenia Gravis | 14 |
| Autoimmune Diseases of the Nervous System | 8 |
| Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease | 7 |
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 7 |
| Encephalomyelitis, Acute Disseminated | 6 |
| Myositis | 5 |
| Guillain-Barre Syndrome | 3 |
| Lupus Erythematosus, Systemic | 3 |
Trials
Showing 51 to 52 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.